β¨ Government Appointments and Medicines Consent
5 JUNE 2014 NEW ZEALAND GAZETTE, No. 59 1631
Foreign Affairs and Trade
Dated this Tuesday, the 13th day of May 2014.
HON MURRAY MCCULLY, Minister of Foreign Affairs.
go3419
Crown Entities Act 2004
Reappointment to the Board of Management of the New Zealand Antarctic Institute
Pursuant to section 28 of the Crown Entities Act 2004,
I reappoint
Robert Fenwick
as the chair of the New Zealand Antarctic Institute Board, as established under the New Zealand Antarctic Institute Act 1996, for a term commencing on 30 June 2014 and expiring on 30 June 2015.
Reappointment to the Board of Management of the New Zealand Antarctic Institute
Pursuant to section 28 of the Crown Entities Act 2004,
I reappoint
Phillip Melchior
as a member of the New Zealand Antarctic Institute Board, as established under the New Zealand Antarctic Institute Act 1996, for a term commencing on 1 July 2014 and expiring on 30 June 2017.
Dated this Tuesday, the 13th day of May 2014.
HON MURRAY MCCULLY, Minister of Foreign Affairs.
go3420
Health
Medicines Act 1981
Consent to the Distribution of New Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:
Schedule
Product: Alustal Extract of Five Grasses (Initial Treatment)
Active Ingredients: Allergen extracts 0.1IR/mL (Vial 1)
Allergen extracts 1IR/mL (Vial 2)
Allergen extracts 10IR/mL (Vial 3)
Dosage Form: Solution for injection
New Zealand Sponsor: Ebos Group Limited
Manufacturer: Stallergenes SA, Antony, France
Product: Alustal Extract of Five Grasses (Maintenance Treatment)
Active Ingredient: Allergen extracts 10IR/mL
Dosage Form: Solution for injection
New Zealand Sponsor: Ebos Group Limited
Manufacturer: Stallergenes SA, Antony, France
Product: Lucentis
Active Ingredient: Ranibizumab 10mg/mL
Dosage Form: Solution for injection
New Zealand Sponsor: Novartis New Zealand Limited
Manufacturers: Novartis Pharma Stein AG, Stein, Switzerland
Vetter Pharma-Fertigung GmbH & Co KG, Langenargen, Germany
Sterigenics Belgium SA, Verviers, Belgium
Product: Oralair (Initial Treatment)
Active Ingredients: Grass pollen extract 100IR (Tablet 1)
Allergen extracts 300IR (Tablet 2)
Dosage Form: Sublingual tablet
New Zealand Sponsor: Ebos Group Limited
Manufacturers: Delpharm Lille SAS, Lys Lez Lannoy, France
Cenexi SAS, Osny, France
Next Page →
β¨ LLM interpretation of page content
π Reappointment to the Board of Management of the New Zealand Antarctic Institute
π External Affairs & Territories13 May 2014
Reappointment, New Zealand Antarctic Institute, Board of Management, Chair
- Robert Fenwick, Reappointed as chair of the New Zealand Antarctic Institute Board
- HON MURRAY MCCULLY, Minister of Foreign Affairs
π Reappointment to the Board of Management of the New Zealand Antarctic Institute
π External Affairs & Territories13 May 2014
Reappointment, New Zealand Antarctic Institute, Board of Management, Member
- Phillip Melchior, Reappointed as member of the New Zealand Antarctic Institute Board
- HON MURRAY MCCULLY, Minister of Foreign Affairs
π₯ Consent to the Distribution of New Medicines
π₯ Health & Social WelfareMedicines, Distribution, Consent, Medicines Act 1981
NZ Gazette 2014, No 59